Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kaisa Teittinen"'
Autor:
Olivia Hölsä, Kaisa Teittinen, Anna Anttalainen, Liisa Ukkola-Vuoti, Milla Summanen, Kalle E Mattila
Publikováno v:
Therapeutic Advances in Urology, Vol 15 (2023)
Background: Novel receptor tyrosine kinase inhibitors and immune checkpoint inhibitors have been introduced to the treatment of advanced renal cell carcinoma (aRCC) during the past decade. However, the adoption of novel treatments into clinical pract
Externí odkaz:
https://doaj.org/article/f704f7eb566c4909b2111516953cd9ba
Autor:
Merja Heinäniemi, Tapio Vuorenmaa, Susanna Teppo, Minna U Kaikkonen, Maria Bouvy-Liivrand, Juha Mehtonen, Henri Niskanen, Vasilios Zachariadis, Saara Laukkanen, Thomas Liuksiala, Kaisa Teittinen, Olli Lohi
Publikováno v:
eLife, Vol 5 (2016)
Progression of malignancy to overt disease requires multiple genetic hits. Activation-induced deaminase (AID) can drive lymphomagenesis by generating off-target DNA breaks at loci that harbor highly active enhancers and display convergent transcripti
Externí odkaz:
https://doaj.org/article/3c703075f0d84e4b921da632d6e73ade
Autor:
Jukka Westermarck, William C. Hahn, Hannu Haapasalo, Juergen Kast, Shujun Lin, Kirsi Ketola, Olayinka Raheem, Kaisa Teittinen, Melissa E. Hector, Anna A. Sablina, Sari Vanhatupa, Melissa R. Junttila, Pietri Puustinen
Extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase pathway activity is regulated by the antagonist function of activating kinases and inactivating protein phosphatases. Sustained ERK pathway activity is commonly observed in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3118af823a771241764483ca2ae7d791
https://doi.org/10.1158/0008-5472.c.6499386.v1
https://doi.org/10.1158/0008-5472.c.6499386.v1
Autor:
Jukka Westermarck, William C. Hahn, Hannu Haapasalo, Juergen Kast, Shujun Lin, Kirsi Ketola, Olayinka Raheem, Kaisa Teittinen, Melissa E. Hector, Anna A. Sablina, Sari Vanhatupa, Melissa R. Junttila, Pietri Puustinen
Supplementary Tables 1-3, Figures 1-6 from PME-1 Protects Extracellular Signal-Regulated Kinase Pathway Activity from Protein Phosphatase 2A–Mediated Inactivation in Human Malignant Glioma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae289e1f223410633bb3ffd4981a677e
https://doi.org/10.1158/0008-5472.22379901
https://doi.org/10.1158/0008-5472.22379901